Workflow
muscular dystrophies treatment
icon
搜索文档
Edgewise Therapeutics to Present on Sevasemten for Becker and Duchenne Muscular Dystrophies at the 30th International Annual Congress of the World Muscle Society
Prnewswire· 2025-10-02 20:00
Details of the Edgewise symposium and scientific posters at WMS: Edgewise Symposium with Key Opinion Leaders Date:Â Wednesday, October 8, 2025, at 7 pm CET Title:Â Breakthroughs in Becker: Unveiling New Natural History Insights and a Novel Agent's Clinical Progress Accessibility StatementSkip Navigation BOULDER, Colo., Oct. 2, 2025 /PRNewswire/ --Â Edgewise Therapeutics, Inc., (Nasdaq: EWTX), a leading muscle disease biopharmaceutical company, today announced its participation at the 30th International Annu ...